Psychiatric illness and poverty mark a higher suicide hazard in HIV care

People living with HIV in Taiwan faced a measurable rise in suicide-related events when psychiatric illness, sleep disturbance, and socioeconomic disadvantage entered the picture. In an 18-year national cohort, these factors did not appear as abstract social variables; they tracked with hospitalizations for suicide attempts and deaths by suicide in a population already carrying the burden of chronic infection and long-term treatment.

The study followed 32,250 people aged 15 years and older who were diagnosed with HIV between 2001 and 2018 and then observed through 2022. Investigators used linked records from Taiwan’s National Health Insurance Research Database and defined the outcome as the first suicide-related event, either a suicide attempt requiring hospitalization or death by suicide. Follow-up for outcome assessment began only after a 3-year window following HIV diagnosis, a design choice that excluded the earliest period after diagnosis and focused on people who remained event-free long enough to enter the analytic cohort.

During follow-up, 943 suicide-related events were recorded, corresponding to 359.72 per 100,000 person-years. Those events were not evenly distributed. People with psychiatric disorders carried a higher hazard of suicide-related events than those without the condition, with an adjusted hazard ratio of 1.53 and a 95% confidence interval of 1.19 to 1.96. Depression was also associated with increased risk, with an adjusted hazard ratio of 1.35, while sleep disturbance carried an adjusted hazard ratio of 1.26.

The pattern fits clinical reality. Depression, insomnia, and broader psychiatric comorbidity can intensify hopelessness, impair judgment, and weaken adherence to HIV care, while also amplifying impulsivity and emotional pain. In a population living with a stigmatized chronic infection, these symptoms can compound each other rather than appear in isolation.

Socioeconomic disadvantage and emergency care use added to the risk burden

Social and economic conditions also carried weight. A monthly insured salary below NT$25,000 was associated with a higher hazard of suicide-related events, placing financial strain among the clinically relevant risk markers in this cohort. So did HIV transmission through injection drug use, blood transfusion, or unknown routes. In addition, having at least one emergency department visit per year was linked to increased hazard.

Those associations are not merely administrative footnotes. Lower income can restrict access to stable housing, routine outpatient follow-up, transportation, and mental health care. Frequent emergency department use may reflect unstable medical or psychiatric needs, fragmented care, or crisis-driven contact with the health system rather than sustained longitudinal support. In HIV care, these signals matter because suicide prevention often depends on identifying patients who are not surfacing in psychiatric clinics but are repeatedly appearing in acute care settings.

The cohort design also makes the timing of risk more clinically interesting. By beginning outcome follow-up after the 3-year post-diagnosis window, the analysis concentrated on longer-term survivorship rather than the immediate shock period after an HIV diagnosis. Suicide risk in that later phase may be shaped less by the initial diagnostic crisis and more by accumulating psychiatric burden, social disadvantage, and the wear of chronic disease management.

A 3-year window separates early diagnosis from later survivorship risk

The investigators examined psychiatric comorbidities and sleep disturbance during the 3 years after HIV diagnosis, then started outcome follow-up at the end of that interval. This approach helps distinguish baseline vulnerabilities from subsequent suicide events. It also means the results should be read as risk among people who survived event-free to 3 years after diagnosis, not among all people newly diagnosed with HIV.

That distinction is important in clinical practice. The findings do not imply that every patient with HIV and depression will attempt suicide, nor do they define a single causal pathway. They do show that psychiatric illness, depressed mood, and sleep problems cluster with markedly higher hazard over long-term follow-up. For clinicians managing HIV, the signal is strong enough to justify routine screening that goes beyond viral control and CD4 monitoring.

The biological and behavioral plausibility is straightforward. Sleep disturbance can worsen affect regulation and executive function, depression can impair self-care and magnify hopelessness, and psychiatric illness can erode protective relationships and treatment engagement. When those factors are layered on top of socioeconomic hardship, the threshold for crisis becomes lower.

HIV care teams may need routine suicide screening built into follow-up

The study points toward integration rather than separation of services. HIV care that ignores mental health risks misses part of the mortality burden; mental health care that ignores HIV status misses a chronic medical context that shapes vulnerability. A practical response would include repeated screening for depression, sleep problems, substance-related risk, and suicide-related thoughts or behaviors, particularly in patients with low income, repeated emergency department use, or histories linked to injection drug use.

The authors also reported no competing interests, and the work was supported by Taiwan’s National Science and Technology Council and An Nan Hospital, with approvals from the relevant institutional review board and access authorized through the national insurance database governance process. These features strengthen the administrative backbone of the study, but they do not turn retrospective association into proof of benefit from any intervention.

Prospective studies remain necessary to test whether structured mental health screening, sleep assessment, social support, and targeted psychosocial care can actually reduce suicide attempts and deaths in people living with HIV. Until then, the cohort provides a clear warning: psychiatric burden and poverty are not peripheral in HIV follow-up, and they travel with a higher hazard of suicide-related events long after diagnosis.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by Nature Medical Research.